Grow Your Wealth
with Mutual Funds
UTI Healthcare Fund Direct-idcw
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 1,308.0 Cr.
NAV as on 03 aug, 2026
₹ 296.47
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
UTI Healthcare Fund Direct-idcw
Inception Date
01 Jan 2013
Lock In
No Lock-in
SIP Minimum Investment amount
₹500
SWP Minimum Investment amount
₹500
STP Minimum Investment amount
₹100
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
95.05%
Debt
0.01%
Cash
4.95%
Portfolio Updated on: 07 Jul, 2026
Sector Allocations
Equity
Healthcare
Portfolio Updated on: 03 aug, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.54% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.54% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.76% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.77% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.49% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.87% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.99% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.42% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.61% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.61% |
Debt & Credit Risk Analysis
| Alpha | 1.82% |
| Beta | 0.95% |
| R2 | 0.96% |
| Sharpe Ratio | 1.10% |
| Standard Deviation | 15.92% |
| Sortino Ratio | 1.73% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 15.35% | NA | 6.12% |
| 6 Months | 21.90% | NA | 12.92% |
| 9 Months | 15.55% | NA | 4.47% |
| 1 Year | 16.65% | 16.65% | 6.04% |
| 2 Years | 30.28% | 14.14% | 24.93% |
| 3 Years | 93.68% | 24.65% | 25.71% |
| 5 Years | 107.96% | 15.77% | 19.91% |
| 7 Years | 362.34% | 24.45% | NA |
| 10 Years | 298.96% | 14.84% | 12.78% |
UTI Healthcare Fund Direct-idcw is one Equity mutual fund offered by UTI Mutual Fund. Launched on 01 Jan 2013, the fund aims Long term capital appreciation. Investment in equity instruments following a value investment strategy across the market capitalization spectrum. It manages assets worth ₹1,308.0 crore as on Tue Jun 30, 2026. The expense ratio stands at 1.27%.
Kamal Gada has experience Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund-growth | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| SBI Healthcare Opportunities Fund-idcw | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| DSP Healthcare Fund Direct-growth | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| DSP Healthcare Fund Direct-idcw | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| Mirae Asset Healthcare Fund Direct-growth | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
| Mirae Asset Healthcare Fund Direct-idcw | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from UTI Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| UTI Healthcare Fund Regular Plan-growth | 1,308.0 | +2.21% | +15.06% | +21.33% | +15.53% | +23.44% | +14.59% |
| UTI Healthcare Fund Direct-growth | 1,308.0 | +2.29% | +15.35% | +21.90% | +16.65% | +24.65% | +15.77% |
| UTI Healthcare Fund Regular Plan-idcw | 1,308.0 | +2.21% | +15.06% | +21.33% | +15.53% | +23.44% | +14.59% |
growth is based on 1-month returns of the funds
Top Mutual Funds
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹595.67 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹413.85 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹514.75 | +23.32% | +16.75% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹324.27 | +23.32% | +16.75% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.77 | +24.03% | +16.63% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.85 | +24.03% | +16.63% | — |
| Dsp Healthcare Fund Direct-growth | ₹49.33 | +21.00% | +15.99% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.53 | +21.00% | +15.99% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹51.65 | +23.87% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹31.11 | +23.87% | +15.83% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 03 Aug 2026 | ₹296.47 |
| 31 Jul 2026 | ₹294.46 |
| 30 Jul 2026 | ₹294.05 |
| 29 Jul 2026 | ₹295.08 |
| 28 Jul 2026 | ₹291.00 |
| 27 Jul 2026 | ₹291.90 |
| 24 Jul 2026 | ₹286.95 |
| 23 Jul 2026 | ₹287.53 |
| 22 Jul 2026 | ₹289.34 |
| 21 Jul 2026 | ₹293.98 |
| 20 Jul 2026 | ₹293.56 |
| 17 Jul 2026 | ₹291.31 |
| 16 Jul 2026 | ₹294.87 |
| 15 Jul 2026 | ₹293.83 |
| 14 Jul 2026 | ₹292.36 |
| 13 Jul 2026 | ₹290.97 |
| 10 Jul 2026 | ₹290.54 |
| 09 Jul 2026 | ₹288.91 |
| 08 Jul 2026 | ₹284.71 |
| 07 Jul 2026 | ₹288.19 |
| 06 Jul 2026 | ₹290.26 |
| 03 Jul 2026 | ₹289.83 |
| 02 Jul 2026 | ₹287.30 |
| 01 Jul 2026 | ₹285.99 |
| 30 Jun 2026 | ₹286.86 |
| 29 Jun 2026 | ₹283.77 |
| 25 Jun 2026 | ₹282.10 |
| 24 Jun 2026 | ₹283.22 |
| 23 Jun 2026 | ₹281.78 |
| 22 Jun 2026 | ₹279.95 |
Portfolio Updated on: 04 Aug, 2026
Fund Growth & Size Analysis
+₹1,308.0 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
UTI Healthcare Fund Direct-idcw Returns Comparison
Compare UTI Healthcare Fund Direct-idcw with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
UTI Healthcare Fund Di....
No funds found for your search.
UTI Healthcare Fund Direct-idcw FAQ'S
- Sharpe Ratio: 1.10%
- Standard Deviation: 15.92%
- Beta: 0.95%
- Alpha: 1.82%
- R-squared: 0.96%
- Information Ratio: 0.32%
- Sortino Ratio: 1.73%
Additional important ratios:
As of Tue Jun 30, 2026, the total assets managed under UTI Healthcare Fund Direct-idcw stand at approximately ₹ 1,308.0 crore.
The UTI Healthcare Fund Direct-idcw has delivered the following short-term performance:
- 3 Months Return: 15.35%
- 6 Months Return: 21.90%
The historical growth of the UTI Healthcare Fund Direct-idcw is reflected through its CAGR returns:
- 3 Year CAGR: 24.65%
- 5 Year CAGR: 15.77%
- Return Since Launch: 16.57%
The portfolio of UTI Healthcare Fund Direct-idcw is distributed across different asset classes as follows:
- Equity: 95.05%
- Debt Instruments: 0.01%
- Other Assets: 4.95%
The UTI Healthcare Fund Direct-idcw is managed by Kamal Gada, representing UTI Mutual Fund.
The UTI Healthcare Fund Direct-idcw investments are allocated across market caps in the following manner:
- Large Cap Stocks: 19.45%
- Mid Cap Stocks: 34.54%
- Small Cap Stocks: 46.01%
Top stock holdings of UTI Healthcare Fund Direct-idcw include:
- Sun Pharmaceutical Industries Ltd – represents 8.54% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 8.54% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.76% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.77% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.49% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 8.87% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.99% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.42% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.61% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.61% of the portfolio
Major sector exposures in UTI Healthcare Fund Direct-idcw are:
- Healthcare – accounts for 1,215.81% of the portfolio
